8-86905083-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_173538.3(CNBD1):c.161G>A(p.Arg54Gln) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000321 in 1,589,286 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/23 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_173538.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CNBD1 | NM_173538.3 | c.161G>A | p.Arg54Gln | missense_variant, splice_region_variant | 3/11 | ENST00000518476.6 | NP_775809.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CNBD1 | ENST00000518476.6 | c.161G>A | p.Arg54Gln | missense_variant, splice_region_variant | 3/11 | 1 | NM_173538.3 | ENSP00000430073.1 | ||
CNBD1 | ENST00000523299.6 | c.161G>A | p.Arg54Gln | missense_variant, splice_region_variant | 3/13 | 3 | ENSP00000430986.2 | |||
CNBD1 | ENST00000517748.1 | n.215G>A | splice_region_variant, non_coding_transcript_exon_variant | 3/4 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000658 AC: 10AN: 151986Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000416 AC: 10AN: 240550Hom.: 0 AF XY: 0.0000384 AC XY: 5AN XY: 130364
GnomAD4 exome AF: 0.0000285 AC: 41AN: 1437300Hom.: 0 Cov.: 26 AF XY: 0.0000279 AC XY: 20AN XY: 715792
GnomAD4 genome AF: 0.0000658 AC: 10AN: 151986Hom.: 0 Cov.: 32 AF XY: 0.0000674 AC XY: 5AN XY: 74216
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 30, 2022 | The c.161G>A (p.R54Q) alteration is located in exon 3 (coding exon 3) of the CNBD1 gene. This alteration results from a G to A substitution at nucleotide position 161, causing the arginine (R) at amino acid position 54 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at